National Trends in Heart Failure and Acute Myocarditis-Related Death Before and During the COVID-19 Pandemic
- PMID: 40371584
- PMCID: PMC12184568
- DOI: 10.1161/JAHA.124.038987
National Trends in Heart Failure and Acute Myocarditis-Related Death Before and During the COVID-19 Pandemic
Abstract
Background: The COVID-19 pandemic saw a rise in cardiovascular death, likely the result of disruptions in health care delivery and the infection itself. We examine mortality trends of heart failure (HF) and acute myocarditis (AM) before and during the pandemic and identify the most affected demographic subgroups.
Methods and results: We queried the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database for deaths from HF and AM before (1999-2019) and during (2020-2021) the COVID-19 pandemic. Age-adjusted mortality rates were calculated and stratified by sex, race and ethnicity, and age category. Trend-level analysis was performed using the Joinpoint Regression Program, which estimates average annual percentage change (AAPC) in age-adjusted mortality rate with corresponding 95% CI. A total of 7 366 944 HF deaths and 33 750 AM deaths occurred during 1999 to 2021. HF and AM mortality rates downtrended before the pandemic (AAPC, -0.63 and -2.42, respectively) but reversed during the pandemic (HF AAPC, 7.91; and AM AAPC, 20.3). Overall, during the pandemic, the age-adjusted mortality rate for both HF and AM was greater for men, non-Hispanic Black people, and adults aged ≥65 years. The sharpest increase was observed among non-Hispanic American Indian people (AAPC, 14.9), Hispanic people (AAPC, 9.63), and young adults (AAPC, 20.9) for HF and among women (AAPC 18.7), non-Hispanic Black people (AAPC, 15.6), and older adults (AAPC, 23.5) for AM.
Conclusions: The prepandemic downward trends of HF and AM mortality rates have reversed since 2020. Subgroups that had the greatest absolute mortality rates from both AM and HF in the pandemic years were men, non-Hispanic Black people, and older adults (aged ≥65 years).
Keywords: COVID‐19 pandemic; acute myocarditis; cardiovascular death; heart failure.
Conflict of interest statement
None.
Figures


Similar articles
-
Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic.JAMA Netw Open. 2024 Oct 1;7(10):e2438918. doi: 10.1001/jamanetworkopen.2024.38918. JAMA Netw Open. 2024. PMID: 39392630 Free PMC article.
-
Projected Trends in Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality Through 2040.JAMA Netw Open. 2025 Jun 2;8(6):e2516367. doi: 10.1001/jamanetworkopen.2025.16367. JAMA Netw Open. 2025. PMID: 40526381 Free PMC article.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2023 Nov 30;11:CD015395. doi: 10.1002/14651858.CD015395.pub3. PMID: 36126225 Free PMC article. Updated.
References
-
- Boehmer TK, Kompaniyets L, Lavery AM, Hsu J, Ko JY, Yusuf H, Romano SD, Gundlapalli AV, Oster ME, Harris AM. Association between COVID‐19 and myocarditis using hospital‐based administrative data—United States, March 2020–January 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1228–1232. doi: 10.15585/mmwr.mm7035e5 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous